Talk to us

Recent blog posts

Could platelets block your drug's path to success?

Platelets do far more than halt the flow of blood. So how might they interact with your drug candidate? Intentionally or unintentionally, a drug that triggers platelet activity unfolds a dramatic chain of events.

Which questions should we be asking in preclinical testing?

Immuneed Chief Operating Officer share first-hand experience from taking a drug candidate from preclinical testing to first in human trials - without testing on animals. "It was clear from the outset that safety testing on mice would have no relevance for our drug’s potential to succeed in humans. Nonetheless, many said it would...

When is complement activation a risk?

Preclinical testing is vital to ensure the safety of clinical trials, so why is a key aspect of the body’s immune system almost systematically overlooked in preclinical assays? Complement activation is a risk – even if the classical pathway is blocked...
1
2